MORGAN STANLEY PLC/CALL/CENTENE/105/0.1/20.06.25 Stock

Warrant

DE000ME3CYP7

Real-time Bid/Ask 06:09:16 2024-06-19 am EDT
0.076 EUR / 0.094 EUR -4.49% Intraday chart for MORGAN STANLEY PLC/CALL/CENTENE/105/0.1/20.06.25
Current month-15.24%
1 month-58.41%
Date Price Change
24-06-19 0.075 -15.73%
24-06-18 0.089 0.00%
24-06-17 0.089 -1.11%
24-06-14 0.09 +7.14%
24-06-13 0.084 -6.67%

Delayed Quote Börse Stuttgart

Last update June 19, 2024 at 06:00 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CENTENE CORPORATION
Issuer Morgan Stanley
WKN ME3CYP
ISINDE000ME3CYP7
Date issued 2023-11-09
Strike 105 $
Maturity 2025-06-20 (367 Days)
Parity 10 : 1
Emission price 0.33
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.58
Lowest since issue 0.075
Delta0.11x
Omega 7.902
Premium59.54x
Gearing72.35x
Moneyness 0.6323
Difference Strike 38.61 $
Difference Strike %+36.77%
Spread 0.019
Spread %20.00%
Theoretical value 0.0845
Implied Volatility 29.44 %
Total Loss Probability 93.70 %
Intrinsic value 0.000000
Present value 0.0845
Break even 105.91 €
Theta-0x
Vega0.01x
Rho0.01x

Company Profile

Centene Corporation specializes in health services. Revenues break down by activity as follows: - development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons; - specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
Sector
-
More about the company

Ratings for Centene Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Centene Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
66.39 USD
Average target price
88.29 USD
Spread / Average Target
+32.99%
Consensus